Radiopharm Theranostics: A unique cancer treatment with solid early trial results 
Listen to Radiopharm Theranostics Managing Director Riccardo Canevari talk to Matt Birney on the Bulls N’ Bears Report about Radiopharm’s UK trial for its cancer treatment that is designed to seek and destroy tumours.See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

Radiopharm Theranostics: A unique cancer treatment with solid early trial results Listen to Radiopharm Theranostics Managing Director Riccardo Canevari talk to Matt Birney on the Bulls N’ Bears Report about Radiopharm’s UK trial for its cancer treatment that is designed to seek and destroy tumours. See omnystudio.com/listener for privacy information.

Radiopharm Theranostics: A unique cancer treatment with solid early trial results 
Listen to Radiopharm Theranostics Managing Director Riccardo Canevari talk to Matt Birney on the Bulls N’ Bears Report about Radiopharm’s UK trial for its cancer treatment that is designed to seek and destroy tumours.See <a href="https://omnystudio.com/listener" rel="noopener noreferrer">omnystudio.com/listener</a> for privacy information.

Radiopharm Theranostics: A unique cancer treatment with solid early trial results

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N&rsquo; Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia&rsquo;s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Business

Investing

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Share Radiopharm Theranostics: A unique cancer treatment with solid early trial results

Sign up to save your podcasts

Radiopharm Theranostics: A unique cancer treatment with solid early trial results

Radiopharm Theranostics: A unique cancer treatment with solid early trial results

More shows like Bulls N' Bears with Matt Birney

AFL Trade Radio

NAB Morning Call

Equity Mates Investing Podcast

Australian Investors Podcast

Money of Mine

The Explorers Podcast with Barry FitzGerald

Buy Hold Sell, by Livewire Markets

The Call from ausbiz

Market Updates

Footy Classified